Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation
Publication Date: October 12, 2022
Last Updated: October 24, 2022
General Recommendations
The laboratory may use in silico data files to supplement NGS analytical validation, particularly to assess analytical sensitivity or false-negative rates for specific variants; however, in silico data files cannot supplant the use of physical samples (eg, patient samples).
6731
Title
Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation
Authoring Organization
Association for Molecular Pathology